James R Burton

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. ncbi request reprint Liver transplantation in mushroom poisoning
    James R Burton
    Department of Medicine, GI Unit Hepatology Section Strong, Memorial Hospital, Rochester, New York, USA
    J Clin Gastroenterol 35:276-80. 2002
  2. ncbi request reprint Use of hepatitis B core antibody-positive donors in recipients without evidence of hepatitis B infection: a survey of current practice in the United States
    James R Burton
    Division of Gastroenterology Hepatology, Oregon Health and Sciences University, Portland, OR 97239, USA
    Liver Transpl 9:837-42. 2003
  3. ncbi request reprint Retransplantation for recurrent hepatitis C in the MELD era: maximizing utility
    James R Burton
    Division of Gastroenterology Hepatology, Oregon Health and Science University, Portland, OR, USA
    Liver Transpl 10:S59-64. 2004
  4. ncbi request reprint Liver retransplantation for hepatitis C virus recurrence: a survey of liver transplant programs in the United States
    James R Burton
    Division of Gastroenterology Hepatology, Oregon Health and Science University and Portland Veterans Administration Medical Center, Portland, Oregon 97239, USA
    Clin Gastroenterol Hepatol 3:700-4. 2005
  5. pmc Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C
    Norah A Terrault
    Department of Medicine, University of California San Francisco, San Francisco, California 94143 0538, USA
    Clin Gastroenterol Hepatol 6:1403-11. 2008
  6. ncbi request reprint Treatment of HCV recurrence: do the pretransplantation rules apply?
    James R Burton
    Liver Transpl 12:1044-8. 2006
  7. ncbi request reprint Retransplantation for hepatitis C: what do we really know?
    James R Burton
    Liver Transpl 10:1504-6. 2004
  8. ncbi request reprint Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study
    Timothy McCashland
    Department of Hepatology, University of Nebraska Medical Center, Omaha, NE 68198 3285, USA
    Liver Transpl 13:1246-53. 2007
  9. ncbi request reprint Acute rejection in HCV-infected liver transplant recipients: The great conundrum
    James R Burton
    Division of Gastroenterology and Hepatology, Liver Transplantation Program and Hepatitis C Research Center, University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, USA
    Liver Transpl 12:S38-47. 2006
  10. ncbi request reprint Diagnosis and management of allograft failure
    James R Burton
    Division of Gastroenterology and Hepatology, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, B154, Denver, CO 80262, USA
    Clin Liver Dis 10:407-35, x. 2006

Detail Information

Publications14

  1. ncbi request reprint Liver transplantation in mushroom poisoning
    James R Burton
    Department of Medicine, GI Unit Hepatology Section Strong, Memorial Hospital, Rochester, New York, USA
    J Clin Gastroenterol 35:276-80. 2002
    ..We present a case of FHF related to mushroom poisoning that required liver transplantation. The clinical presentation, medical management, and prognostic criteria in mushroom poisoning are discussed...
  2. ncbi request reprint Use of hepatitis B core antibody-positive donors in recipients without evidence of hepatitis B infection: a survey of current practice in the United States
    James R Burton
    Division of Gastroenterology Hepatology, Oregon Health and Sciences University, Portland, OR 97239, USA
    Liver Transpl 9:837-42. 2003
    ..Treatment protocols for using these organs varied. Knowledge about HBV DNA status of the donor and/or liver would greatly influence prophylaxis for those accepting anti-HBc(+) donor livers...
  3. ncbi request reprint Retransplantation for recurrent hepatitis C in the MELD era: maximizing utility
    James R Burton
    Division of Gastroenterology Hepatology, Oregon Health and Science University, Portland, OR, USA
    Liver Transpl 10:S59-64. 2004
    ..Utility starts to decline at MELD scores above 28. 5. The current allocation system (MELD) fails to maximize utility with regard to re-LT...
  4. ncbi request reprint Liver retransplantation for hepatitis C virus recurrence: a survey of liver transplant programs in the United States
    James R Burton
    Division of Gastroenterology Hepatology, Oregon Health and Science University and Portland Veterans Administration Medical Center, Portland, Oregon 97239, USA
    Clin Gastroenterol Hepatol 3:700-4. 2005
    ..To gain insight into how transplant centers are dealing with this issue and whether published prognostic factors are being used, we conducted a survey of liver transplant centers across the US in late 2003...
  5. pmc Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C
    Norah A Terrault
    Department of Medicine, University of California San Francisco, San Francisco, California 94143 0538, USA
    Clin Gastroenterol Hepatol 6:1403-11. 2008
    ..Prior studies suggest the rate of liver fibrosis progression is slower in African Americans (AAs) than Caucasian Americans (CAs) with chronic HCV infection...
  6. ncbi request reprint Treatment of HCV recurrence: do the pretransplantation rules apply?
    James R Burton
    Liver Transpl 12:1044-8. 2006
  7. ncbi request reprint Retransplantation for hepatitis C: what do we really know?
    James R Burton
    Liver Transpl 10:1504-6. 2004
  8. ncbi request reprint Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study
    Timothy McCashland
    Department of Hepatology, University of Nebraska Medical Center, Omaha, NE 68198 3285, USA
    Liver Transpl 13:1246-53. 2007
    ..MELD scores were not predictive of post-reTX survival. Survival was <50% in the non-HCV reTx group with MELD score of >30. Many patients with recurrent HCV are not considered for reTX and die from recurrent disease...
  9. ncbi request reprint Acute rejection in HCV-infected liver transplant recipients: The great conundrum
    James R Burton
    Division of Gastroenterology and Hepatology, Liver Transplantation Program and Hepatitis C Research Center, University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, USA
    Liver Transpl 12:S38-47. 2006
    ..6. Mild rejection per se is not associated with graft loss and treatment of rejection with steroids and OKT3 is associated with worse outcome in HCV; thus, it seems logical that we should no longer treat mild rejection...
  10. ncbi request reprint Diagnosis and management of allograft failure
    James R Burton
    Division of Gastroenterology and Hepatology, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, B154, Denver, CO 80262, USA
    Clin Liver Dis 10:407-35, x. 2006
    ..It also discusses the complex problems involved in retransplantation for allograft failure...
  11. ncbi request reprint Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence
    Lucy Golden-Mason
    Division of Gastroenterology and Hepatology, Hepatitis C Center, and Integrated Program in Immunology, University of Colorado Health Sciences Center and National Jewish Hospital, Denver, CO, USA
    Hepatology 44:1098-109. 2006
    ..These data provide a mechanistic basis for the observation that CTLs generated in early infection rapidly decline as chronicity is established; CD127 expression should be considered in the design of novel immunotherapeutic approaches...
  12. ncbi request reprint Validation of a multivariate model predicting presence and size of varices
    James R Burton
    Division of Gastroenterology and Hepatology, University of Colorado Health Sciences University, Denver, CO 80262, USA
    J Clin Gastroenterol 41:609-15. 2007
    ..A model developed by our group identified low platelets and advanced Child-Pugh class (CPC) as being associated with large varices...
  13. ncbi request reprint Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy
    Hugo R Rosen
    Integrated Program in Immunology and Hepatitis C Research Center, Division of Gastroenterology and Hepatology, University of Colorado, Denver, CO, USA
    Hepatology 46:350-8. 2007
    ..007). ELISPOT response was independently associated with SVR by multivariable analysis...
  14. doi request reprint Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection
    Susan Smyk-Pearson
    Division of Gastroenterology and Hepatology, Hepatitis C Center, University of Colorado Health Sciences Center, GI Division, 4200 E 9th Ave, B 158, Denver, CO 80262, USA
    J Infect Dis 197:46-57. 2008
    ....